![]() |
Francis Van Parys, GE Healthcare Korea CEO |
GE Healthcare appointed Francis Van Parys as the new head of its Korean unit, replacing outgoing CEO Sia Moussavi who has moved to Canada to oversee the firm's multi-vendor service unit there.
Prior to joining GE Healthcare, Van Parys held several key positions in marketing and sales within GE Life Sciences and Consumer & Industrial divisions. He was also recognized for his ability in sales force effectiveness and deployment, GE Healthcare Korea said Monday.
The company said he is a general manager with a strong track record of delivering results in senior leadership roles in portfolio management, commercial operations and sales and marketing.
In addition, Van Parys has gained substantial global experience acquired from working in healthcare, life sciences and industrial business units within GE.
"I am very confident the extensive experience and leadership capabilities Van Parys has accumulated in the global healthcare market will bring a new era of partnership with Korean customers, including medical professionals and biopharmaceutical industry experts," said Sean Burke, CEO of GE Healthcare Asia Pacific.
"He is the right person to accelerate the growth of GE Healthcare Korea as we strive to expand our presence in the nation's rapidly growing biopharmaceutical market," he said.
Early in his career, he drove significant market share gains in the electrical distribution markets in Europe, the Middle East and Africa (EMEA) by optimising go-to-market and channel strategies, GE Healthcare said.
The Belgian later led the consolidation of commercial operations and customer service teams for GE Life Sciences EMEA, based in Amersham, United Kingdom.
As the product general manager for research business in Life Sciences, he propelled a business turnaround by revitalising product strategies, optimizing the portfolio and delivering a new product pipeline.
Van Parys was also credited for accelerating growth with pharmaceutical and biotech customers to strengthen GE's position in upstream bioprocessing.
He received a master's degree in materials science and engineering from the University of Ghent in Belgium. He also holds a master of science in polymer technology from the University of Manchester Institute of Science and Technology.